T1	intervention 20 44	shenqi fuzheng injection
T2	outcome 1441 1487	myelosuppression and gastrointestinal reaction
T3	outcome 1298 1324	progression of the disease
T5	outcome 1363 1390	grade IV toxic side effects
T7	outcome 1080 1100	total effective rate
T8	iv-bin-percent 1105 1110	69.2%
T9	iv-bin-abs 1112 1114	45
T10	intervention-participants 1115 1117	65
T11	cv-bin-percent 1142 1147	49.2%
T12	cv-bin-abs 1149 1151	30
T13	control-participants 1152 1154	61
T14	control 539 552	control group
T15	control-participants 556 558	61
T16	intervention-participants 616 618	65
T18	total-participants 384 387	126
T19	eligibility 388 430	patients with local advanced breast cancer
